top of page
Johns hopkins hospital

Working to cure cancer

At Suman Paul Laboratory, we are focused on building new therapies for cancer treatment. Our team is working on identifying novel cancer targets and generating antibodies and cell therapies to exploit the cancer targets.  

Publications

Antibodies to treat T cell leukemias and lymphomas

Our latest publication detailing the development of bispecific antibodies that selectively kill T cell leukemias and lymphomas and do not harm the normal human T cells

Science Translational Medicine 2021

Antibody targeting cancers with p53 mutation

Mutations in p53 tumor suppression gene leads to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

Science 2021

Antibodies targeting cancers with RAS mutations

Mutations in RAS oncogene lead to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

Science Immunology 2021

Links

Location

1650 Orleans Street, CRB1, Room 3M90, Baltimore, MD 21287

Contacts

419-614-3900

  • Twitter
  • LinkedIn

Research Support

American_Society_of_Hematology_logo.svg.png
National_Cancer_Institute_logo.svg.png
1199px-LLS_logo_.jpg
saa-logo_full-color.jpg
SITC_edited.jpg
university_logo_small_vertical_blue.png
bottom of page